Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Justin Zelin is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/10/2025 | IBRX | Buy Now | ImmunityBio | $2.90 | 106.9% | Justin Zelin41% | → $6 | Initiates | → Buy | Get Alert |
| 12/13/2024 | ELVN | Buy Now | Enliven Therapeutics | $17.19 | 144.33% | Justin Zelin41% | → $42 | Initiates | → Buy | Get Alert |
| 12/10/2024 | CARM | Buy Now | CARISMA Therapeutics | $0.22 | — | Justin Zelin41% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/26/2024 | PSTX | Buy Now | Poseida Therapeutics | — | — | Justin Zelin41% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/09/2024 | IDYA | Buy Now | IDEAYA Biosciences | $17.11 | 262.36% | Justin Zelin41% | $55 → $62 | Maintains | Buy | Get Alert |
| 07/08/2024 | JSPR | Buy Now | Jasper Therapeutics | $4.20 | 2042.86% | Justin Zelin41% | → $90 | Initiates | → Buy | Get Alert |
| 05/16/2024 | TCRX | Buy Now | TScan Therapeutics | $1.30 | 823.08% | Justin Zelin41% | → $12 | Initiates | → Buy | Get Alert |
| 05/06/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.11 | — | Justin Zelin41% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/11/2024 | CARM | Buy Now | CARISMA Therapeutics | $0.22 | 2596.63% | Justin Zelin41% | → $6 | Initiates | → Buy | Get Alert |
| 03/26/2024 | VKTX | Buy Now | Viking Therapeutics | $24.77 | 404.64% | Justin Zelin41% | $100 → $125 | Maintains | Buy | Get Alert |
| 03/15/2024 | VKTX | Buy Now | Viking Therapeutics | $24.77 | 303.71% | Justin Zelin41% | $86 → $100 | Maintains | Buy | Get Alert |
| 03/08/2024 | IDYA | Buy Now | IDEAYA Biosciences | $17.11 | 221.45% | Justin Zelin41% | → $55 | Initiates | → Buy | Get Alert |
| 12/26/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | Justin Zelin41% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/21/2023 | VSTM | Buy Now | Verastem | $4.93 | 447.83% | Justin Zelin41% | → $27 | Assumes | → Buy | Get Alert |
| 10/06/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.11 | 14172.12% | Justin Zelin41% | → $15 | Assumes | → Buy | Get Alert |
| 08/15/2023 | MBIO | Buy Now | Mustang Bio | $1.38 | 1059.42% | Justin Zelin41% | $1000 → $800 | Maintains | Buy | Get Alert |
| 08/11/2023 | IMCR | Buy Now | Immunocore Hldgs | $26.92 | 238.04% | Justin Zelin41% | $85 → $91 | Maintains | Buy | Get Alert |
| 08/10/2023 | ACET | Buy Now | Adicet Bio | $0.58 | 1624.14% | Justin Zelin41% | $20 → $10 | Maintains | Buy | Get Alert |
| 07/25/2023 | PROK | Buy Now | ProKidney | $0.79 | 1915.88% | Justin Zelin41% | → $16 | Initiates | → Buy | Get Alert |
| 07/03/2023 | ETNB | Buy Now | 89bio | $5.92 | 525% | Justin Zelin41% | $30 → $37 | Maintains | Buy | Get Alert |
| 06/26/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $11.24 | 211.39% | Justin Zelin41% | $34 → $35 | Maintains | Buy | Get Alert |
| 06/16/2023 | MBIO | Buy Now | Mustang Bio | $1.38 | 1349.28% | Justin Zelin41% | $200 → $1000 | Maintains | Buy | Get Alert |
| 06/13/2023 | LEGN | Buy Now | Legend Biotech | $32.00 | 181.25% | Justin Zelin41% | $85 → $90 | Maintains | Buy | Get Alert |
| 06/13/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | Justin Zelin41% | $18 → $20 | Maintains | Buy | Get Alert |
| 05/17/2023 | KURA | Buy Now | Kura Oncology | $5.85 | 429.91% | Justin Zelin41% | → $31 | Initiates | → Buy | Get Alert |
| 05/16/2023 | VKTX | Buy Now | Viking Therapeutics | $24.77 | 45.34% | Justin Zelin41% | $31 → $36 | Maintains | Buy | Get Alert |
| 04/20/2023 | LEGN | Buy Now | Legend Biotech | $32.00 | 165.63% | Justin Zelin41% | $75 → $85 | Maintains | Buy | Get Alert |
| 03/29/2023 | VKTX | Buy Now | Viking Therapeutics | $24.77 | 25.15% | Justin Zelin41% | $20 → $31 | Maintains | Buy | Get Alert |
| 03/28/2023 | NVO | Buy Now | Novo Nordisk | $65.80 | -52.89% | Justin Zelin41% | $10 → $15.5 | Maintains | Buy | Get Alert |
| 12/06/2022 | MEIP | Buy Now | MEI Pharma | $2.20 | — | Justin Zelin41% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/16/2022 | CASI | Buy Now | CASI Pharmaceuticals | $1.93 | 418.13% | Justin Zelin41% | $21 → $10 | Maintains | Buy | Get Alert |
| 11/16/2022 | MBIO | Buy Now | Mustang Bio | $1.38 | 189.86% | Justin Zelin41% | $6000 → $3000 | Maintains | Buy | Get Alert |
| 08/02/2022 | IMCR | Buy Now | Immunocore Hldgs | $26.92 | 215.75% | Justin Zelin41% | → $85 | Initiates | → Buy | Get Alert |
| 06/29/2022 | ETNB | Buy Now | 89bio | $5.92 | 305.41% | Justin Zelin41% | $28 → $24 | Maintains | Buy | Get Alert |
| 06/03/2022 | CASI | Buy Now | CASI Pharmaceuticals | $1.93 | 988.08% | Justin Zelin41% | $4 → $21 | Maintains | Buy | Get Alert |
| 04/04/2022 | GRCL | Buy Now | Gracell Biotechnologies | — | — | Justin Zelin41% | → $18 | Initiates | → Buy | Get Alert |
| 03/25/2022 | MEIP | Buy Now | MEI Pharma | $2.20 | 81.82% | Justin Zelin41% | $220 → $80 | Maintains | Buy | Get Alert |
| 07/29/2021 | BLU | Buy Now | BELLUS Health | — | — | Justin Zelin41% | → $9 | Initiates | → Buy | Get Alert |
| 05/18/2021 | SURF | Buy Now | Surface Oncology | — | — | Justin Zelin41% | → $17 | Initiates | → Buy | Get Alert |
| 05/18/2021 | PSTX | Buy Now | Poseida Therapeutics | — | — | Justin Zelin41% | → $40 | Initiates | → Buy | Get Alert |
| 05/18/2021 | MBIO | Buy Now | Mustang Bio | $1.38 | 697.1% | Justin Zelin41% | → $8250 | Initiates | → Buy | Get Alert |
| 05/18/2021 | ACET | Buy Now | Adicet Bio | $0.58 | 5762.07% | Justin Zelin41% | → $34 | Initiates | → Buy | Get Alert |
| 05/18/2021 | CASI | Buy Now | CASI Pharmaceuticals | $1.93 | 107.25% | Justin Zelin41% | → $40 | Initiates | → Buy | Get Alert |
| 02/13/2019 | MEIP | Buy Now | MEI Pharma | $2.20 | — | Justin Zelin41% | — | Initiates | → Buy | Get Alert |
